HTAtlas
← Back to explore

Approaches to Aggregation and Decision Making—A Health Economics Approach

Methodpeer-reviewed

This framework helps decision makers combine different types of evidence, especially health outcomes and costs, to assess the value of health interventions using economic principles. It supports structured thinking about what makes a treatment valuable.

At a glance

Use when

When developing or evaluating value assessment frameworks, conducting health technology assessments, or designing reimbursement policies

Avoid when

When a purely clinical or non-economic perspective is sufficient, or when economic data are unavailable and cannot be reasonably estimated

Inputs

Clinical outcomes, cost data, patient-reported outcomes, preference weights

Outputs

Aggregated value measures, decision recommendations based on economic efficiency and equity

How it works

A conceptual and methodological framework developed by the ISPOR Special Task Force for aggregating outcomes and informing decision making in health technology assessment and value-based pricing. It applies health economics principles to integrate clinical, economic, and patient-centered outcomes into coherent value assessments.

HTA domains
Clinical Effectiveness, Costs & Economic Evaluation
Assumptions
Outcomes can be meaningfully measured and weighted; decision makers seek value for money; equity and patient preferences are relevant to value
Strengths
Provides a structured, transparent approach to value assessment; integrates economic efficiency with equity and patient-centered considerations; developed by a multidisciplinary expert group
Limitations
May require subjective judgments in weighting outcomes; implementation depends on data availability and stakeholder consensus; not a quantitative model itself but a guiding framework

Questions this answers

References & sources

Related methods

Similar by meaning

Beta record. Based on the original catalogue summary; primary-source enrichment pending.